Rafferty Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-143,589
| Closed | -$2.9M | – | 1349 |
|
|
2021
Q3 | $2.9M | Buy |
143,589
+73,769
| +106% | +$1.49M | 0.02% | 498 |
|
|
2021
Q2 | $2.61M | Sell |
69,820
-50,037
| -42% | -$1.87M | 0.02% | 578 |
|
|
2021
Q1 | $3.07M | Buy |
119,857
+97,384
| +433% | +$2.49M | 0.02% | 477 |
|
|
2020
Q4 | $495K | Sell |
22,473
-51,689
| -70% | -$1.14M | ﹤0.01% | 688 |
|
|
2020
Q3 | $1.33M | Buy |
74,162
+46,611
| +169% | +$838K | 0.02% | 527 |
|
|
2020
Q2 | $700K | Buy |
+27,551
| New | +$700K | 0.01% | 630 |
|
|
2020
Q1 | – | Sell |
-29,364
| Closed | -$647K | – | 861 |
|
|
2019
Q4 | $647K | Sell |
29,364
-43,882
| -60% | -$967K | 0.01% | 649 |
|
|
2019
Q3 | $1.05M | Buy |
73,246
+9,323
| +15% | +$134K | 0.02% | 526 |
|
|
2019
Q2 | $1.01M | Buy |
63,923
+681
| +1% | +$10.7K | 0.02% | 562 |
|
|
2019
Q1 | $926K | Buy |
+63,242
| New | +$926K | 0.01% | 563 |
|